Mednet Logo
HomePediatric Hematology/Oncology
Pediatric Hematology/Oncology

Pediatric Hematology/Oncology

Clinical discussions on pediatric blood disorders, childhood cancers, and specialized treatment protocols.

Recent Discussions

How will you use Pola-R-CHP in the frontline treatment of DLBCL?

4
3 Answers

Mednet Member
Mednet Member
Medical Oncology · Cleveland Clinic

Given the comparable toxicity profile and the lower rate of treatment failure, the number needed to treat (n=16) is low enough that this is very appropriate to be the new standard of care. Although overall survival was not different, fewer patients treated with the Pola-R-CHP regimen required subseq...

How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?

2 Answers

Mednet Member
Mednet Member
Hematology · Mayo Clinic

This can be a complex question for which there are likely no specific data or guidelines upon which to base a recommendation. ASH has published guidelines on thrombophilia testing in VTE (Middeldorp et al., PMID 37195076). They specifically recommend against testing prior to COC prescription. The ra...

Is your standard of care for newly diagnosed advanced classical Hodgkin now nivolumab-AVD based on SWOG 1826?

5 Answers

Mednet Member
Mednet Member
Medical Oncology · Lurie Comp Cancer Center of Northwestern Univ

I think the new standard of care for newly diagnosed patients with advanced classical Hodgkins Lymphoma is now nivolumab-AVD based on the early data from SWOG 1826. While we often wait for more mature data, the early improvement in PFS and the more favorable toxicity profile of this regimen over BvA...

Do you offer fertility preservation to patients prior to CAR-T therapy?

1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Phoenix Childrens Medical Group

There is no evidence yet about the impact of CAR-T itself on fertility, and this will be difficult to study in isolation in this population. Many CAR-T patients have been heavily pre-treated, so semen cryopreservation and oocyte harvesting may not be successful; but if feasible they should be attemp...

What is your approach to chronic non-immune mediated thrombocytopenia management in children?

1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · St. Jude Children’s Research Hospital

There are whole textbook chapters on this topic, and we use a variant of this question to review the differential diagnosis of thrombocytopenia with our fellows as a didactic exercise. So I take from this question, which is an important one, what might be a framework to consider the differential dx ...

What criteria is needed in relapsed/refractory B-cell ALL to choose CAR-T therapy over conventional stem cell transplant as destination therapy?

3 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Northwestern University Feinberg School of Medicine

Currently, there are no standard criteria used to choose CAR-T over conventional stem cell transplant as destination therapy. However, there are many factors that often push us in one direction or the other. As we learn more about outcomes after CAR-T cell therapy, there are many factors we know are...

How would you manage a child with subtotal resection of an atypical choroid plexus papilloma?

2 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · C. S. Mott Children’s Hospital, University of Michigan

Data from the SickKids Hospital study strongly suggest that the extent of resection is prognostic in atypical CPP, and in the presence of GTR, chemotherapy may be avoided or skipped entirely (Browne-Farmer et al., PMID 34529227). The role of adjuvant treatment in the setting of incompletely resected...

When do you consider including Rituximab into the treatment regimen for a pediatric or AYA patient with intermediate and advanced-stage nodular lymphocyte-predominant Hodgkin lymphoma?

1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · University of Colorado School of Medicine - Anschutz Medical Campus

First, I would want to make sure the diagnosis is correct as advanced stage NLPHL is extremely rare. T-cell rich B-cell lymphoma can look identical histologically. Either way, R-CHOP therapy is good therapy for both.

How would you manage a recurrent pineoblastoma following prior CSI?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Cleveland Clinic

Recurrent pineoblastoma following prior CSI represents a challenging clinical scenario. As there is very little published data to guide optimal management, our approach is adopted from recurrent medulloblastoma. The prognosis for patients with recurrent medulloblastoma/PNET is poor, with 5-year OS <...

Can aplastic anemia present with multiple infiltrative bone lesions, such as in the spine and pelvis?

3 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · St Jude Children's Research Hospital

There are several studies showing diffuse hypointense pictures with an infiltrative-like pattern on MRI in aplastic anemia and MDS. Some aplastic anemia and refractory cytopenia of childhood show patchy pattern of hematopoiesis with some regions having increased fat fraction and some remnants of hem...